Chandler AZ 乳腺癌临床试验
5项针对 乳腺癌的研究正在 Chandler及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
招募中3 期
- Ironwood Cancer & Research Centers ( Site 0066), Chandler
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
招募中3 期
- Ironwood Cancer & Research Centers, Chandler
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
招募中3 期
- Ironwood Cancer & Research Centers, Chandler
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
招募中3 期
- Ironwood Cancer and Research Centers, Chandler
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
招募中3 期
- Ironwood Cancer & Research Centers, Chandler
其他城市的 乳腺癌试验
- New York City, NY136 项研究
- Houston, TX126 项研究
- Boston, MA112 项研究
- Nashville, TN81 项研究
- Los Angeles, CA73 项研究
- Edison, NJ68 项研究
- St. Louis, MO64 项研究
- Queens, NY64 项研究
- Durham, NC64 项研究
- Chicago, IL59 项研究
- Philadelphia, PA56 项研究
- Dallas, TX55 项研究
Chandler的其他研究
- 脂肪性肝病10 项研究
- 非小细胞肺癌5 项研究
- 结直肠癌5 项研究
- 肥胖症5 项研究
- 消化系统疾病5 项研究
- 肝脏疾病4 项研究
- 超重4 项研究
- 2型糖尿病4 项研究
- 转移性癌症4 项研究
- 阿尔茨海默病3 项研究
- 心血管疾病3 项研究
- 结肠癌3 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。